Celsion

Small Market Cap Pharmaceuticals With Large Catalysts Looming In 2013
Seeking Alpha
Fri, 11/30/12 - 12:17 pm
Aeterna Zentaris
Celsion
OncoSec Medical
3 Top Biopharma Stocks of 2012
Motley Fool
Fri, 11/30/12 - 12:13 pm
Arena Pharmaceuticals
Celsion
Sarepta Therapeutics
Celsion's Phase III Drug Trials For Thermodox
Seeking Alpha
Wed, 11/28/12 - 10:58 am
Celsion
ThermoDox
breast cancer
colorectal liver metastasis
10 Best-Performing Biopharma Stocks of 2012 and Their 2013 Outlook
TheStreet.com
Tue, 11/27/12 - 11:12 am
Affymax
Pharmacyclics
Galena Biopharma
Threshold Pharmaceuticals
Hemispherx Biopharma
Sunesis
Celsion
Sarepta
Arena Pharmaceuticals
BioDelivery Sciences
First 90 Days of 2013 Are Live or Die For These Biotech Stocks
TheStreet.com
Mon, 11/19/12 - 02:00 pm
Oncothyreon
Celsion
Arena Pharmaceuticals
NuPathe
Hemispherx
Amarin
Biogen Idec
Gilead
Hyperion Therapeutics
Celgene
Raptor Pharmaceuticals
Dynavax
Zogenix
Impax Labs
5 Healthcare Companies With Recent Insider Buying
Seeking Alpha
Mon, 11/19/12 - 11:15 am
Synergy Pharmaceuticals
Progenics
Pacific Biosciences
MAKO
insider trading
Celsion
Celsion: Run-Up Trade Into Thermodox Results
TheStreet.com
Wed, 11/14/12 - 12:31 pm
Celsion
ThermoDox
liver cancer
4 Biotechs That Just Got Mauled By Bears
Seeking Alpha
Wed, 10/10/12 - 12:05 pm
Neuralstem
Peregrine Pharmaceuticals
Celsion
Athersys
4 Under-The-Radar Systems In Biotechnology That Could Create Upside
Seeking Alpha
Sun, 10/7/12 - 11:48 am
OncoSec Medical
Celsion
AngioDynamics
Accuray
Lessons From Biotech's Best Third Quarter Stocks
TheStreet.com
Tue, 10/2/12 - 11:59 am
Celsion
XenoPort
Peregrine Pharmaceuticals
Sunesis
Opexa
StemCells
Catalyst Pharmaceutical Partners
Hemispherx
Sarepta
Savient
3 Pharmaceuticals Pursuing Non-Surgical Approaches To Combating Cancer
Seeking Alpha
Mon, 09/24/12 - 11:18 am
OncoSec
Celsion
AngioDynamics
Bristol-Myers Squibb
cancer
22 Biopharma Stocks With Breakout Potential in 2012
Seeking Alpha
Tue, 05/22/12 - 11:25 am
Ziopharm
Zalicus
EXACT Sciences
Geron
Lexicon Pharmaceuticals
Nektar
Vical
Celgene
Celsion
ChemoCentryx
Clovis Oncology
Eli Lilly
JNJ
Pfizer
Elan
Biomarin
Biogen Idec
Auxilium
Arqule
Anthera
Acadia
Amicus Therapeutics
Vertex Pharmaceuticals
M&A Activity and a Growing Rate of FDA Approvals Contributing Factors to Biotech Industry's Success The Paragon Report Provides Stock Research on AEterna Zentaris and Celsion
Fri, 05/18/12 - 06:53 pm
M&A
FDA
biotech
Aeterna Zentaris
Celsion
BIO CEO Conference Live Blog
TheStreet.com
Mon, 02/13/12 - 10:30 am
BIO CEO Conference
Celsion
Cyclacel
Navidea Biopharmaceuticals
Chelsea Therapeutics
Titan
Galena Biopharma
Oxigene
Celsion Completes Consultative Review Process With EMA for Phase III HEAT Study of ThermoDox(R) in Primary Liver Cancer
Mon, 12/19/11 - 06:05 pm
Celsion
EMA
ThermoDox
hepatocellular carcinoma
liver cancer
radio frequency ablation
Mangrove Partners asks Celsion to explore alternatives, appoint two to board
Fri, 12/2/11 - 09:02 pm
Celsion
Management
Celsion Corporation to Raise $15 Million in Private Placement
Thu, 12/1/11 - 09:33 pm
Celsion
funding
Celsion Reports Third Quarter 2011 Financial Results and Provides Business Updates
Thu, 11/10/11 - 10:26 pm
Celsion
earnings
3 Cancer-Fighting Stocks That Could Deliver Huge Gains
Seeking Alpha
Sat, 10/8/11 - 11:46 am
ThermoDox
Celsion
liver cancer
Threshold Pharmaceuticals
TH-302
leukemia
Medivation
dimebon
Alzheimer's disease
MDV3100
prostate cancer
Pfizer
Celsion Announces Approval of New Jersey Economic Development Authority Incentive Grant
Thu, 08/18/11 - 09:45 pm
Celsion
New Jersey
development
grant

Pages